Menu
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Everywhere
Threads
This forum
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Info Obat dan Regulator Obat Dunia
Prev
1
…
Go to page
Go
40
41
42
43
44
…
Go to page
Go
126
Next
First
Prev
42 of 126
Go to page
Go
Next
Last
Filters
Show only:
Loading…
F
Navigating the First ICH Generic Drug Draft Guideline “M13A Bioequivalence for Immediate-Release Solid Oral Dosage Forms” - 05/02/2023
FDA
Apr 4, 2023
Replies
0
Views
416
Apr 4, 2023
FDA
F
F
FDA grants accelerated approval to enfortumab vedotin-ejfv with pembrolizumab for locally advanced or metastatic urothelial carcinoma
FDA
Apr 4, 2023
Replies
0
Views
217
Apr 4, 2023
FDA
F
F
Mitigation Strategies for Nitrosamine Drug Substance Related Impurities: Quality and Bioequivalence Considerations for Generic Products - 06/15/2023
FDA
Apr 4, 2023
Replies
0
Views
308
Apr 4, 2023
FDA
F
F
Identification of Medicinal Products — Implementation and Use
FDA
Apr 1, 2023
Replies
0
Views
344
Apr 1, 2023
FDA
F
F
Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension, USP 750mg/5mL Due to Potential Bacillus Cereus Contamin
FDA
Apr 1, 2023
Replies
0
Views
226
Apr 1, 2023
FDA
F
F
Procter & Gamble Manufactura S. de R.L. de C.V. - 650837 - 03/27/2023
FDA
Apr 1, 2023
Replies
0
Views
343
Apr 1, 2023
FDA
F
F
Drug Disposal: Questions and Answers
FDA
Apr 1, 2023
Replies
0
Views
226
Apr 1, 2023
FDA
F
E
Regulatory information – adjusted fees for applications to EMA from 1 April 2023, , 31/03/2023
EMA
Apr 1, 2023
Replies
0
Views
378
Apr 1, 2023
EMA
E
E
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27 - 30 March 2023, CHMP, 31/03/2023
EMA
Apr 1, 2023
Replies
0
Views
256
Apr 1, 2023
EMA
E
E
EMA recommends approval of Bimervax as a COVID-19 booster vaccine, CHMP, 30/03/2023
EMA
Apr 1, 2023
Replies
0
Views
225
Apr 1, 2023
EMA
E
F
Tris Pharma, Inc Expands Its Voluntary Nationwide Retail Recall of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, Due to Higher Concentratio
FDA
Mar 31, 2023
Replies
0
Views
294
Mar 31, 2023
FDA
F
F
The History of Drug Regulation
FDA
Mar 31, 2023
Replies
0
Views
272
Mar 31, 2023
FDA
F
F
Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Softw
FDA
Mar 31, 2023
Replies
0
Views
212
Mar 31, 2023
FDA
F
F
2020 Meeting Materials, Psychopharmacologic Drugs Advisory Committee
FDA
Mar 31, 2023
Replies
0
Views
218
Mar 31, 2023
FDA
F
F
FDA Approves First Over-the-Counter Naloxone Nasal Spray
FDA
Mar 30, 2023
Replies
0
Views
232
Mar 30, 2023
FDA
F
F
OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2023 User Fees and Registration - 05/16/2023
FDA
Mar 30, 2023
Replies
0
Views
212
Mar 30, 2023
FDA
F
F
Access to Naloxone Can Save a Life During an Opioid Overdose
FDA
Mar 30, 2023
Replies
0
Views
214
Mar 30, 2023
FDA
F
F
FDA launches Lupus Treatment Consortium in partnership with the Lupus Research Alliance
FDA
Mar 30, 2023
Replies
0
Views
278
Mar 30, 2023
FDA
F
E
DARWIN EU® has completed its first studies and is calling for new data partners, , 28/03/2023
EMA
Mar 29, 2023
Replies
0
Views
344
Mar 29, 2023
EMA
E
F
NuGeneration Technologies LLC - 645821 - 03/13/2023
FDA
Mar 29, 2023
Replies
0
Views
287
Mar 29, 2023
FDA
F
Prev
1
…
Go to page
Go
40
41
42
43
44
…
Go to page
Go
126
Next
First
Prev
42 of 126
Go to page
Go
Next
Last
You must log in or register to post here.
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
Top